Although IL-33 treatment lowered the percentages of CD4+ T cells, NK cells and CD4+Foxp3+ Tregs among liver non-leukemia leukocytes (GFP−CD45+), there were no significant differences in absolute numbers of different immune subsets tested except for an increase of MDSCs (Figure 2B). This evidence concerns the gene IL33 and leukemia.